Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Debiopharm International SA
Information provided by (Responsible Party):
Debiopharm International SA Identifier:
First received: August 26, 2013
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)